Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial

Arteaga, Carlos; Rojo, Federico; Gonzalez-Perez, Abel; Albanell, Joan; Gamez-Pozo, Angelo; Bellet Ezquerra, Meritxell

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Arteaga, Carlos
dc.contributor.author	Rojo, Federico
dc.contributor.author	Gonzalez-Perez, Abel
dc.contributor.author	Albanell, Joan
dc.contributor.author	Gamez-Pozo, Angelo
dc.contributor.author	Bellet Ezquerra, Meritxell
dc.date.accessioned	2025-08-12T07:57:37Z
dc.date.available	2025-08-12T07:57:37Z
dc.date.issued	2025-06-20
dc.identifier.citation	Albanell J, Gámez Pozo A, Arteaga CL, Bellet M, Rojo F, González A, et al. Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial. npj Breast Cancer. 2025 Jun 20;11:59.
dc.identifier.issn	2374-4677
dc.identifier.uri	http://hdl.handle.net/11351/13527
dc.description	Biomarcadores; Cáncer de mama avanzado; Receptor hormonal positivo
dc.language.iso	eng
dc.publisher	Nature Portfolio
dc.relation.ispartofseries	npj Breast Cancer;11
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Marcadors bioquímics
dc.subject	Proteïnes quinases - Inhibidors - Ús terapèutic
dc.subject	Mama - Càncer - Tractament
dc.subject	Quimioteràpia combinada
dc.subject.mesh	Biomarkers
dc.subject.mesh	Protein Kinase Inhibitors
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Antineoplastic Combined Chemotherapy Protocols
dc.title	Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41523-025-00777-0
dc.subject.decs	biomarcadores
dc.subject.decs	inhibidores de proteínas cinasas
dc.subject.decs	/uso terapéutico
dc.subject.decs	neoplasias de la mama
dc.subject.decs	/farmacoterapia
dc.subject.decs	protocolos de quimioterapia antineoplásica combinada
dc.relation.publishversion	https://doi.org/10.1038/s41523-025-00777-0
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Albanell J] Hospital del Mar Research Institute Barcelona, Depatment of Medical Oncology, Hospital del Mar, Barcelona, Spain. Universitat Pompeu Fabra, Barcelona, Spain. Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain. [Gámez Pozo A] Translational Oncology Lab, University Hospital La Paz - IdiPAZ, Madrid, Spain. [Arteaga CL] UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA. [Bellet M] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Rojo F, González A] Hospital del Mar Research Institute Barcelona, Depatment of Medical Oncology, Hospital del Mar, Barcelona, Spain
dc.identifier.pmid	40541946
dc.identifier.wos	001512768100002
dc.rights.accessrights	info:eu-repo/semantics/openAccess